Description
Fc Engineered Anti-Human SLAMF7 Antibody, CDC-Enhanced (BioBet-C025ZP) is a recombinant monoclonal Whole Humanized antibody against SLAMF7. This product is a CDC enhanced antibody produced by our proprietary platform.
Indication
Refractory Multiple Myeloma
Classification
Therapeutic antibody; biobetter
Cooperation Seeking
Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Elotuzumab. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
SLAMF7
Full Name
SLAM family member 7
Gene ID
57823
UniProt ID
Q9NQ25
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
Humanized IgG1; ADC
Indication
Refractory Multiple Myeloma
Refractory Multiple Myeloma
